This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Covidien PLC (COV)

NYSE: Health Care

Company Income Statement
Sep 2013 Sep 2012 Sep 2011 Sep 2010
Sales 10.24B 11.85B 11.57B 10.43B
Cost of Sales 3.51B 4.40B 4.40B 4.14B
Gross Operating Profit 6.73B 7.45B 7.18B 6.29B
Selling, General, and Administrative Expenses 3.34B 3.69B 3.54B 3.22B
Research & Development 508.00M 623.00M 554.00M 447.00M
Operating Income before D & A (EBITDA) 2.88B 3.14B 3.08B 2.63B
Depreciation & Amortization 642.00M 633.00M 599.00M 489.00M
Interest Income 16.00M 16.00M 22.00M 22.00M
Other Income - Net 89.00M 25.00M 33.00M 40.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 2.24B 2.46B 2.42B 2.12B
Interest Expense 208.00M 206.00M 203.00M 199.00M
Pre-Tax Income 2.03B 2.25B 2.22B 1.93B
Income Taxes 429.00M 347.00M 333.00M 363.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 1.60B 1.90B 1.88B 1.56B
Net Income From Discontinued Operations 100.00M 3.00M -15.00M 69.00M
Net Income From Total Operations 1.70B 1.90B 1.87B 1.63B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.70B 1.90B 1.87B 1.63B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.70B 1.99B 2.00B 1.64B
Preferred Dividends
Net Income Available To Common 1.60B 1.90B 1.88B 1.56B
Basic EPS from Continuing Ops. 3.43 3.96 3.82 3.13
Basic EPS from Discontinued Ops. 0.22 0.01 -0.03 0.14
Basic EPS from Total Operations 3.65 3.97 3.79 3.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.01 -0.01 0.00 -0.01
Basic EPS, Total 3.64 3.96 3.79 3.26
Basic Normalized Net Income/Share 3.66 4.15 4.07 3.28
EPS fr Continuing Ops. 3.40 3.92 3.79 3.10
EPS fr Discontinued Ops 0.21 0.01 -0.03 0.14
EPS fr Total Ops. 3.61 3.93 3.76 3.24
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.01 0.00 0.00
EPS, Total 3.61 3.92 3.76 3.24
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.62 4.11 4.04 3.25
Dividends Paid per Share 1.04 0.90 0.60 0.92
COV News

Analysts Ratings for COV

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 13 13
Moderate Buy 2 3 2 2
Hold 10 9 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET COV ANALYST REPORT

Brokerage Partners

COV Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs